Hyper IgM syndrome

From Wikipedia, the free encyclopedia

The introduction to this article provides insufficient context for those unfamiliar with the subject matter.
Please help improve the introduction to meet Wikipedia's layout standards. You can discuss the issue on the talk page.

The hyper-IgM syndrome is actually a family of genetic immunodeficiencies, as compared to the Acquired Immunodeficiency Syndrome (AIDS). In all types, the level of immunoglobulin M (IgM) is elevated or relatively normal. Some hyper-IgM syndromes are actually deficiencies of the other immunoglobulin classes IgA, IgG, and IgE. IgM is the constitutively expressed form of antibody that all B cells produce prior to class-switching after exposure to recognized antigen. Total neutrophil count is also typically low. Treatment includes IV-Ig infusion. Five types have been characterized:

Hyper IgM Syndrome Type 1, characterized by mutations of the CD40LG gene. T cells can't tell B cells to switch classes.

Hyper IgM Syndrome Type 2, characterized by mutations of the AICDA gene. B cells can't recombine genetic material to change heavy chain production, which a required step in switching classes.

Hyper IgM Syndrome Type 3, characterized by mutations of the CD40 gene. B cells can't receive the signal from T cells to switch classes.

Hyper IgM Syndrome Type 4, which is poorly characterized.

Hyper IgM Syndrome Type 5, characterized by mutations of the UNG gene.